These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 10902629

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Oral contraceptives and prodromal symptoms in fatal pulmonary embolism in young women].
    Kjeldaas L, Jacobsen CD, Laake K, Borchgrevink CF.
    Tidsskr Nor Laegeforen; 1988 May 30; 108(15):1189-90. PubMed ID: 3388343
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May 30; 6(2):4-9, 14. PubMed ID: 12319497
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Editorial: Oral contraceptives and myocardial infarction.
    Shapiro S.
    N Engl J Med; 1975 Jul 24; 293(4):195-6. PubMed ID: 1134533
    [Abstract] [Full Text] [Related]

  • 29. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996 Jul 24; (39):2-3. PubMed ID: 12292198
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
    Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH.
    N Engl J Med; 1988 Nov 17; 319(20):1313-7. PubMed ID: 3185634
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
    Lancet; 1981 Mar 07; 1(8219):541-6. PubMed ID: 6111642
    [Abstract] [Full Text] [Related]

  • 34. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 07; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and the vascular risk of oral contraceptives.
    Plowright C, Adam SA, Thorogood M, Beaumont V, Beaumont JL, Mann JI.
    Br Heart J; 1985 May 07; 53(5):556-61. PubMed ID: 3994871
    [Abstract] [Full Text] [Related]

  • 36. Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
    Hedenmalm K, Samuelsson E, Spigset O.
    Acta Obstet Gynecol Scand; 2004 Jun 07; 83(6):576-85. PubMed ID: 15144341
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme.
    Lancet; 1973 Jun 23; 1(7817):1399-404. PubMed ID: 4126154
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.